Fresh news on health and wellness in Grenada
Provided by AGPChicago, April 03, 2024 (GLOBE NEWSWIRE) -- Gene Expression Analysis market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $6.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Factors like the rising focus on precision medicine and biomarker discovery are fueling the adoption of gene expression profiling technologies. Researchers and healthcare providers are leveraging these tools to identify unique molecular signatures associated with diseases, facilitating early detection and targeted therapies. Moreover, advancements in technology, particularly in next-generation sequencing (NGS) and microarray techniques, are enhancing the efficiency and accuracy of gene expression analysis, making it more accessible across research, clinical, and pharmaceutical sectors.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968
Gene Expression Analysis Market Scope:
| Report Coverage | Details |
| Market Revenue in 2024 | $4.2 billion |
| Estimated Value by 2029 | $6.2 billion |
| Growth Rate | Poised to grow at a CAGR of 8.1% |
| Market Size Available for | 2022–2029 |
| Forecast Period | 2024–2029 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product & Service, Application, and End User |
| Geographies Covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
| Report Highlights | Updated financial information / product portfolio of players |
| Key Market Opportunity | Growing focus on Single-Cell Analysis |
| Key Market Driver | Advancements in gene editing technology |
Based on product & service, the gene expression analysis market is segmented into reagents & consumables, instruments, and services. The reagents & consumables segment is further sub-segmented assays & kits, enzymes, DNA chips, and others. The instruments are further sub-segmented as PCR, NGS, DNA Microarrays, and other instruments. The services are further sub-segmented as gene expression analysis services, and bioinformatics solutions. The reagents & consumables segment accounted for the largest share of the global gene expression analysis market in 2023. The large share of this segment is attributed to the increasing use of reagents & consumables due to the growing volume of genetic tests in drug discovery, biomarker discovery, and pharmacogenomic applications.
Based on application, the gene expression analysis market is segmented into drug discovery & development, clinical diagnostics, and other applications. In 2023, drug discovery & development accounted for the largest share of the gene expression analysis market. The large share of this segment can be attributed to increasing investment in the development and advancement of RNA-based therapeutics. Additionally, the rising availability of investments, grants, and funds is anticipated to boost the market for drug discovery & development applications in the forecast period.
Based on end user, the gene expression analysis market has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2023, pharmaceutical & biotechnology companies accounted for the largest share of the gene expression analysis market. The large share of this segment can be attributed to the rising R&D for pharmaceutical development, growing pipeline of therapeutic drugs, and increasing collaborations among pharma & biotech companies for the development of RNA-based therapeutics.
The key regional markets for the global gene expression analysis market are North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2023, North America accounted for the largest share of the market. The development of gene therapy, focus on gene expression studies, availability of funding for NGS research, increasing R&D spending, and favorable government funding are key factors supporting the growth of the North American gene expression analysis market. However, during the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the increasing investments, partnerships, and collaborations by pharma & biotech companies for genomics research are projected to drive the growth of the gene expression analysis market in Asia Pacific.
Buy a Gene Expression Analysis Industry Report (369 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=156613968
Gene Expression Analysis market major players covered in the report, such as:
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968
This report categorizes the gene expression analysis market into the following segments:
Gene expression analysis market, by Product & Service
Gene expression analysis market, by Application
Gene expression analysis market, by End User
Gene expression analysis market, by region
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=156613968
Key Market Stakeholders:
Report Objectives:
Related Reports:
Bioinformatics Services Market
Next Generation Sequencing Market
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/gene-expression-analysis-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/gene-expression-analysis.asp

About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.